Skip to main content
. 2021 Oct 27;22(21):11621. doi: 10.3390/ijms222111621
RT Radiotherapy
SRS Stereotactic radiosurgery
SABR Stereotactic ablative body radiotherapy
PD-1 Programmed death 1
NSCLC Non-small-cell lung cancer
BED Biological effective dose
ICI Immune checkpoints inhibitors
SBRT Stereotactic body radiotherapy
CTLA-4 Cytotoxic T-Lymphocyte Antigen 4.
PD-L1 Programmed death ligand 1
BM Brain metastases